No difference in rate of adverse cardiovascular events when comparing anticoagulants
In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction and stroke whether they were anticoagulated with bivalirudin or unfractioned heparin, according to a study.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Angiomax | Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Science | Stroke | Study